[The 2-bromo-alpha-ergocryptine test in patients with amenorrhea and galactorrhea].
Two cases with expanding pituitary tumours following treatment with 2-bromo-alpha-ergocryptine are presented. The lack of normal response to the usual therapeutic dose of the drug suggests the presence of an organic hypothalamo-pituitary disorder that might favour the expansion of a pituitary tumour.